Add Yahoo as a preferred source to see more of our stories on Google. Compounded GLP-1 drugs aren't FDA-approved and may carry unknown safety risks. Experts warn of inconsistent quality, dosing and ...
Demand for popular weight loss drugs such as semaglutide (Wegovy) and tirzepatide (Zepbound) has long outpaced supply, forcing many patients with obesity to visit compounding pharmacies to get ...
Over the past few weeks, the FDA has devoted lots of attention to compounding pharmacies, issuing two new guidance documents pertaining to their fundamental scope, a guidance document regarding ...
Especially in women’s health, this former regulatory gray area could help patients who have waited too long for FDA-approved ...
WEST LAFAYETTE, Ind., and INDIANAPOLIS – A Purdue-related startup is developing the first USP 797 certified, virtual pharmacy cleanroom laboratory for students and other industry professionals to gain ...
'Jimmie's Law' provides stricter regulations on pharmaceutical compounding in Kentucky ...
In 2017, the FDA approved semaglutide, an injectable GLP-1 agonist medication sold under the name Ozempic, for the management of type 2 diabetes. Later, the pharmaceutical company that makes Ozempic ...
Compounded GLP-1 drugs aren't FDA-approved and may carry unknown safety risks. Experts warn of inconsistent quality, dosing and possible side effects in compounded meds. Lifestyle habits—like diet, ...
Before you fill that prescription. Reviewed by Dietitian Maria Laura Haddad-Garcia Compounded GLP-1 drugs aren't FDA-approved and may carry unknown safety risks. Experts warn of inconsistent quality, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results